Dimensional Fund Advisors
GMAB icon

Dimensional Fund Advisors’s Genmab GMAB Stock Holding History

Dimensional Fund Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Buy
56,438
+815
+1% +$24.4K ﹤0.01% 2761
2025
Q4 		$1.71M Sell
55,623
-707
-1% -$22K ﹤0.01% 2764
2025
Q3 		$1.73M Buy
56,330
+3,225
+6% +$78.6K ﹤0.01% 2800
2025
Q2 		$1.1M Buy
53,105
+2,284
+4% +$46.9K ﹤0.01% 2870
2025
Q1 		$995K Buy
50,821
+5,206
+11% +$109K ﹤0.01% 2886
2024
Q4 		$952K Sell
45,615
-24,894
-35% -$547K ﹤0.01% 2925
2024
Q3 		$1.72M Sell
70,509
-14,543
-17% -$389K ﹤0.01% 2813
2024
Q2 		$2.14M Sell
85,052
-8,760
-9% -$248K ﹤0.01% 2748
2024
Q1 		$2.81M Buy
93,812
+256
+0.3% +$7.52K ﹤0.01% 2709
2023
Q4 		$2.98M Sell
93,556
-1,228
-1% -$38.6K ﹤0.01% 2695
2023
Q3 		$3.34M Buy
94,784
+1,023
+1% +$39K ﹤0.01% 2641
2023
Q2 		$3.56M Buy
93,761
+19,617
+26% +$782K ﹤0.01% 2629
2023
Q1 		$2.8M Buy
74,144
+13,729
+23% +$528K ﹤0.01% 2652
2022
Q4 		$2.56K Buy
60,415
+5,553
+10% +$229K ﹤0.01% 2661
2022
Q3 		$1.76M Buy
54,862
+1,764
+3% +$61.9K ﹤0.01% 2748
2022
Q2 		$1.73M Buy
53,098
+34,855
+191% +$1.13M ﹤0.01% 2785
2022
Q1 		$660K Buy
18,243
+2,792
+18% +$95.8K ﹤0.01% 3085
2021
Q4 		$611K Buy
15,451
+9,509
+160% +$397K ﹤0.01% 3125
2021
Q3 		$260K Buy
5,942
+660
+12% +$29.6K ﹤0.01% 3305
2021
Q2 		$216K Buy
+5,282
New +$204K ﹤0.01% 3325
2021
Q1 		– Sell
-5,282
Closed -$215K – 3415
2020
Q4 		$215K Buy
+5,282
New +$197K ﹤0.01% 3210

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors's GMAB Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Genmab (GMAB) stake by 1.5% in Q1 2026, buying an estimated $24.4K and bringing the position to 56,438 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2761.

Dimensional Fund Advisors first reported a position in GMAB in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.56M in Q2 2023. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Dimensional Fund Advisors held 56,438 shares of Genmab worth $1.51M as of Q1 2026.
  • Dimensional Fund Advisors bought 815 Genmab shares in Q1 2026, an estimated $24.4K.
  • Genmab made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2761 holding.
  • Dimensional Fund Advisors first reported a position in Genmab in Q4 2020 and has held it in 21 quarters since.
  • Dimensional Fund Advisors's Genmab position peaked at $3.56M in Q2 2023.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.